Merck | MRK - Selling And Administration Expenses

Stock Price
111.90
Daily Change
-0.15 -0.13%
Monthly
5.42%
Yearly
-7.64%
Q2 Forecast
115.40

Merck reported EUR1.6B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Adidas EUR 2.97B 225M Dec/2025
Adyen EUR 141.68M 211.99M Jun/2025
Akzo Nobel EUR 804M 7M Mar/2026
Alcon AG USD 901M 36M Dec/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 18.97M 1.03M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.21B 13M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Beiersdorf EUR 271M 51M Dec/2025
Covestro EUR 445M 8M Dec/2025
Danone EUR 4.7B 170M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Genmab DKK 208M 60M Dec/2025
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Henkel EUR 3.49B 38M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Infineon EUR 409M 8M Dec/2025
Linde USD 880M 40M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
UCB EUR 1.47B 193M Dec/2025